International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-2 doi: 10.5281/zenodo.7913206
Original Article
Clinical Study of Socio-Demographic Factors, Risk Factors and Feto-Maternal Outcome in Early And Late Onset Pre-Eclampsia
 ,
 ,
Published
April 30, 2023
Abstract
Objectives: To study socio-demographic factors and risk factors of women with preeclampsia and to study complications and feto-maternal outcome in early and late onset preeclampsia. Methods: This is a prospective observational study conducted over a period of 2 years. Statistical analysis of data was then done by using SPSS (version 22) for windows and is presented as percentages. Results: In the study, majority of the mothers belonged to the age group of 21 to 25 years (46.2%). Majority had studied till secondary education (56.6%), residing in rural areas (59.4%), and belonging to lower middle class (57.5%). Majority were unbooked cases (72.6%), primigravida (50.0%), with gestational age more than 34 weeks (67.9%), and normal BMI (75.5%).In this study majority were late onset preeclampsia(71.7%).In the study, the condition was severe in majority of the mothers with early onset preeclampsia (60.0%), while the condition of mothers with late onset preeclampsia was non severe in majority (55.3%). In the study, majority of the mothers with early onset pre- eclampsia delivered spontaneously (53.3%), whereas majority with late onset pre-eclampsia required induction for delivering the child (53.9%). The proportion of subjects with complications such as eclampsia, HELLP syndrome, AKI, DIC, PPH, and abruption was more in case of early onset preeclampsia, while the PRES syndrome was present more in case of late onset preeclampsia. Maternal and Fetal mortality and need for resuscitation was more in early onset preeclampsia. Conclusion: Maternal and fetal complications, morbidities and mortality was more in early onset preeclampsia. Thus Preeclampsia must be diagnosed in early pregnancy to prevent its complications. Preventive screening of women for high risk in preeclampsia must be done and existing preventive measures should be applied
Recommended Articles
Loading Image...
Volume-4, Issue-2
Citations
1169 Views
218 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved